Elekta AB EBITDA 2013-2024 | EKTAY
Elekta AB ebitda from 2013 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Elekta AB Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $239 |
| 2022 | $302 |
| 2021 | $356 |
| 2020 | $304 |
| 2019 | $292 |
| 2018 | $267 |
| 2017 | $202 |
| 2016 | $197 |
| 2015 | $195 |
| 2014 | $340 |
| 2013 | $359 |
| 2012 | $314 |
| Elekta AB Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-01-31 | $77 |
| 2023-10-31 | $72 |
| 2023-07-31 | $65 |
| 2023-04-30 | $100 |
| 2023-01-31 | $59 |
| 2022-10-31 | $41 |
| 2022-07-31 | $38 |
| 2022-04-30 | $93 |
| 2022-01-31 | $63 |
| 2021-10-31 | $89 |
| 2021-07-31 | $57 |
| 2021-04-30 | $95 |
| 2021-01-31 | $93 |
| 2020-10-31 | $98 |
| 2020-07-31 | $70 |
| 2020-04-30 | $102 |
| 2020-01-31 | $80 |
| 2019-10-31 | $65 |
| 2019-07-31 | $57 |
| 2019-04-30 | $113 |
| 2019-01-31 | $61 |
| 2018-10-31 | $70 |
| 2018-07-31 | $49 |
| 2018-04-30 | $113 |
| 2018-01-31 | $63 |
| 2017-10-31 | $66 |
| 2017-07-31 | $25 |
| 2017-04-30 | $94 |
| 2017-01-31 | $38 |
| 2016-10-31 | $47 |
| 2016-07-31 | $24 |
| 2016-04-30 | $123 |
| 2016-01-31 | $-1 |
| 2015-10-31 | $58 |
| 2015-07-31 | $17 |
| 2015-04-30 | $69 |
| 2015-01-31 | $19 |
| 2014-10-31 | $42 |
| 2014-07-31 | $-19 |
| 2014-04-30 | $157 |
| 2014-01-31 | $52 |
| 2013-10-31 | $64 |
| 2013-07-31 | $29 |
| 2013-04-30 | $228 |
| 2013-01-31 | $57 |
| 2012-10-31 | $65 |
| 2012-07-31 | $6 |
| 2012-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.461B | $1.704B |
| Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.464B | 27.98 |
| Intuitive Surgical (ISRG) | United States | $174.074B | 98.56 |
| Alcon (ALC) | Switzerland | $48.585B | 34.20 |
| IQVIA Holdings (IQV) | United States | $43.515B | 24.66 |
| Edwards Lifesciences (EW) | United States | $41.276B | 26.46 |
| IDEXX Laboratories (IDXX) | United States | $41.198B | 49.56 |
| DexCom (DXCM) | United States | $27.855B | 39.72 |
| STERIS (STE) | Ireland | $24.144B | 28.17 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.386B | 0.00 |
| Waters (WAT) | United States | $19.344B | 28.84 |
| Hologic (HOLX) | United States | $18.849B | 20.49 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 13.88 |
| Sysmex ADR (SSMXY) | Japan | $12.361B | 0.00 |
| Teleflex (TFX) | United States | $11.593B | 18.03 |
| Globus Medical (GMED) | United States | $9.445B | 26.42 |
| Penumbra (PEN) | United States | $7.261B | 75.38 |
| Glaukos (GKOS) | United States | $6.939B | 0.00 |
| Masimo (MASI) | United States | $6.001B | 32.14 |
| TransMedics (TMDX) | United States | $5.051B | 216.31 |
| Integer Holdings (ITGR) | United States | $4.251B | 24.86 |
| PROCEPT BioRobotics (PRCT) | United States | $4.212B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.878B | 0.00 |
| Inari Medical (NARI) | United States | $2.711B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.635B | 15.45 |
| Veracyte (VCYT) | United States | $2.529B | 156.76 |
| Nihon Kohden (NHNKY) | Japan | $2.515B | 15.65 |
| RxSight (RXST) | United States | $2.033B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.355B | 6.17 |
| Pulse Biosciences (PLSE) | United States | $1.134B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.117B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.103B | 19.67 |
| OPKO Health (OPK) | United States | $1.095B | 0.00 |
| Artivion (AORT) | United States | $1.058B | 97.11 |
| Alphatec Holdings (ATEC) | United States | $0.785B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.782B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 17.17 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.640B | 0.00 |
| Paragon 28 (FNA) | United States | $0.617B | 0.00 |
| IRadimed (IRMD) | United States | $0.614B | 33.20 |
| AxoGen (AXGN) | United States | $0.604B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.350B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.347B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.329B | 10.04 |
| Treace Medical Concepts (TMCI) | United States | $0.318B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.308B | 0.00 |
| Inogen (INGN) | United States | $0.269B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.265B | 0.00 |
| Accuray (ARAY) | United States | $0.217B | 0.00 |
| NeuroPace (NPCE) | United States | $0.217B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.191B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.181B | 12.71 |
| CVRx (CVRX) | United States | $0.171B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.138B | 0.00 |
| 908 Devices (MASS) | United States | $0.125B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.120B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.100B | 14.85 |
| Hyperfine (HYPR) | United States | $0.076B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.064B | 0.00 |
| LENSAR (LNSR) | United States | $0.059B | 0.00 |
| Vaso (VASO) | United States | $0.055B | 14.75 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.031B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Neuronetics (STIM) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |